Search results
Novavax's (NVAX) Updated COVID Jab Gets WHO Nod for Emergency Use
Zacks via Yahoo Finance· 5 months agoNovavax NVAX announced that the World Health Organization (“WHO”) has granted emergency use listing...
Novavax Stock Is Too Sickly To Buy
InvestorPlace via Yahoo Finance· 2 years agoNovavax’s Covid-19 vaccine still isn’t approved for use in the U.S. With the pandemic in full retreat and the majority of people now fully vaccinated,...
Novavax (NVAX) Beats on Q3 Earnings & Sales, Cuts Sales View
Zacks via Yahoo Finance· 5 months agoNovavax (NVAX) reports better-than-expected third-quarter results, with earnings and revenues...
Novavax Covid Vaccine Could Soon Win EUA Approval — And So What?
TipRanks via Yahoo Finance· 2 years agoAt long last, Novavax (NVAX) may be close to getting its EUA. As the company announced late Tuesday,...
Novavax nears FDA advisory meeting date
Yahoo Finance· 2 years agoNovavax signaled a positive outlook for its vaccine pipeline Wednesday with announcements at the World Vaccine Congress and an update on its COVID-19...
Novavax (NVAX) Q4 Earnings & Revenues Miss Estimates, Stock Down
Zacks via Yahoo Finance· 1 year agoNovavax (NVAX) reports worse-than-expected financial performance in the fourth quarter of 2022, with...
Novavax (NVAX) Up as CDC Endorses COVID Jab for Use in Adults
Zacks via Yahoo Finance· 2 years agoFollowing the endorsement by the U.S. CDC, Novavax (NVAX) can now start immunizations with its...
Novavax Stock Looks Like a Good Value With Its New Combined Vaccine
InvestorPlace via Yahoo Finance· 2 years agoNovavax (NVAX) is down from a peak of $217.32 on Dec. 17 to just $53.69, reaching a new low. The...
Is It Too Late to Buy Novavax Stock?
Motley Fool· 1 year agoBiotech company Novavax (NASDAQ: NVAX) has had a terrible year on the stock market, with its shares down by 86% year to date. The company does still face...
Novavax, Inc. (NASDAQ:NVAX) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 months agoNovavax, Inc. (NASDAQ:NVAX) Q4 2023 Earnings Call Transcript February 28, 2024 Novavax, Inc. misses...
